A 4-year pilot study on the efficacy and safety of Implanon®, a single-rod hormonal contraceptive implant, in healthy women in Thailand

European Journal of Contraception and Reproductive Health Care

Volumn 3, Issue 2, 1998, Pages 85-91

  Kiriwat, O ^a   Patanayindee, A ^b   Koetsawang, S ^a   Korver, T ^c   Coelingh Bennink, H J T ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

^c NV ORGANON   (Netherlands)

Author keywords

Bleeding patterns; Efficacy; Hormonal contraceptive implant; Safety

Indexed keywords

3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; VINYL DERIVATIVE;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MENSTRUAL CYCLE; PILOT STUDY; REFERENCE VALUE; THAILAND;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FEMALE; HUMANS; MENSTRUAL CYCLE; PILOT PROJECTS; REFERENCE VALUES; THAILAND; VINYL COMPOUNDS;

EID: 0032091002     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189809051409     Document Type: Article

References (19)

1. Alvarez-Sanchez F, Brache V, Faundes A. Recent experience with and future directions of contraceptive implants and injectable contraceptives. Curr Opin Obstet Gynecol 1993; 5: 805-14
2. Cravioto MC, Alvarado G, Canto-de-Cetina T, Bassol S, Oropeza G, Santos-Yung R, et al. A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant® and Norplant®-II. Contraception 1997; 55: 359-67
3. Buckshee K, Chatterjee P, Dhall GI, Hazra MN, Kodkany BS, Lalitha K, et al. Return of fertility following discontinuation of Norplant®-II implants. Contraception 1995; 51: 237-42
4. Fotherby K. Clinical experience and pharmacological effects of an oral contraceptive containing 20 μg oestrogen. Contraception 1992; 31: 367-94
5. Diaz S, Pavez M, Moo-Young AJ, Bardin CW, Croxatto HB. Clinical trial with 3-keto-desogestrel subdermal implants. Contraception 1991; 44: 393-408
6. Newton JR, Davies G, Li XF, Mascarenhas L, Newton P. Women's health today: perspectives on current research and clinical practice. In Popkin DR, Peddle LJ, eds. Proceedings of the 14th World Congress of Gynecology and Obstetrics, Montreal, September 1994. Carnforth, UK: Parthenon Publishing, 1994: 399-404
7. World Health Organization. WHO Adverse Reaction Dictionary. Uppsala, Sweden: WHO Collaborating Centre for International Drug Monitoring, 1994
8. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 1986; 34: 253-60
9. Belsey EM, Farley TMM. The analysis of menstrual bleeding patterns: a review. Contraception 1988; 38: 129-56
10. Tukey JW. Exploratory Data Analysis. Reading: Addison-Wesley Publishing Company, 1977
11. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980
12. Chompootaweep S, Kochagarn E, Sirisumpan S, Tang-Usaha J, Theppisaksak B, Dusitsin N. Effectiveness of Norplant® implants among Thai women in Bangkok. Contraception 1996; 53: 33-6
13. Peralta O, Diaz S, Croxatto H. Subdermal contraceptive implants. J Steroid Biochem Mol Biol 1995; 53: 223-6
14. Belsey EM, Pinol APY, Task Force on Long-acting Systemic Agents for Fertility Regulations. Menstrual bleeding patterns in untreated women. Contraception 1997; 55: 57-65
15. Bromham DR. Contraceptive implants. Br Med J 1996; 312: 1555-6
16. McCauley AP, Geller JS. Decision for Norplant Programmes. Population Reports, Series K, No.4. Baltimore: Johns Hopkins University, Population Information Program, September 1992
17. Mansour D. Long-acting, reversible methods of contraception. Contemp Rev Obstet Gynecol 1994; 6: 89-94
18. Newton JR. New hormonal methods of contraception. Bailliere's Clin Obstet Gynecol 1996; 10: 87-101
19. Darney PD. Subdermal progestin implant contraception. Curr Sci 1991; 3: 470-6